Literature DB >> 22531956

Minimal mesh repair for apical and anterior prolapse: initial anatomical and subjective outcomes.

Manhan K Vu1, Juraj Letko, Kelly Jirschele, Adam Gafni-Kane, Aimee Nguyen, Honyan Du, Roger P Goldberg.   

Abstract

INTRODUCTION AND HYPOTHESIS: Here we describe anatomic and quality of life (QOL) outcomes of an anterior and apical compartment prolapse repair involving a reduced mesh implant size and apex-only fixation.
METHODS: One hundred and fifteen patients undergoing the repair at a single urogynecology center were assessed using the Pelvic Organ Prolapse Quantification (POP-Q) and inpatient chart reviews. A horizontal incision eliminated overlap with the mesh, and each sacrospinous ligament was approached anteriorly by blunt dissection. Recurrence was defined as apical (C), or anterior (Aa or Ba) ≥0, and secondary analyses were performed using POP-Q ≥ -1 as the anatomic threshold. Pelvic Floor Distress Inventory (PFDI), Surgical Satisfaction Questionnaires (SSQ) and a dyspareunia symptom scale were analyzed pre- and postoperatively.
RESULTS: Fifty-three women with uterus in situ demonstrated a combined anterior-apical recurrence rate of 1.89 %, including no anterior (Ba ≥ -1) and one apical (C ≥ -1) recurrence. Forty-seven women undergoing repair for vault prolapse had recurrence rates ranging from 0 % in those with prior hysterectomy to 4.2 % in those undergoing concurrent hysterectomy. The rate of mesh exposure was 3/115 (2.6 %), including two in women with concurrent hysterectomy. Self-reported dyspareunia was more common preoperatively (13.4 %) than postoperatively (9.3 %). PFDI scores improved in all domains, and 93 % completing the SSQ reported they were satisfied and would choose the surgery again.
CONCLUSIONS: This technique resulted in successful outcomes within both anterior and apical compartments with a low rate of mesh complication, and no cases required mesh removal or hospital readmission. High rates of satisfaction and improved condition-specific QOL were observed.

Entities:  

Mesh:

Year:  2012        PMID: 22531956     DOI: 10.1007/s00192-012-1780-5

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

1.  Arcus-anchored acellular dermal graft compared to anterior colporrhaphy for stage II cystoceles and beyond.

Authors:  Sylvia M Botros; Peter K Sand; Jennifer L Beaumont; Yoram Abramov; Jay James Miller; Roger P Goldberg
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-17

2.  Bilateral anterior sacrospinous ligament suspension associated with a paravaginal repair with mesh: short-term clinical results of a pilot study.

Authors:  Renaud de Tayrac; Laurent Boileau; Jean-François Fara; François Monneins; Charles Raini; Pierre Costa
Journal:  Int Urogynecol J       Date:  2010-03       Impact factor: 2.894

3.  Prospective randomized trial of polyglactin 910 mesh to prevent recurrence of cystoceles and rectoceles.

Authors:  P K Sand; S Koduri; R W Lobel; H A Winkler; J Tomezsko; P J Culligan; R Goldberg
Journal:  Am J Obstet Gynecol       Date:  2001-06       Impact factor: 8.661

4.  The relationship between anterior and apical compartment support.

Authors:  Aimee Summers; Lisa A Winkel; Hero K Hussain; John O L DeLancey
Journal:  Am J Obstet Gynecol       Date:  2006-03-30       Impact factor: 8.661

5.  Advanced anterior vaginal wall prolapse is highly correlated with apical prolapse.

Authors:  Kristin Rooney; Kimberly Kenton; Elizabeth R Mueller; Mary Pat FitzGerald; Linda Brubaker
Journal:  Am J Obstet Gynecol       Date:  2006-12       Impact factor: 8.661

6.  Vaginal mesh for prolapse: a randomized controlled trial.

Authors:  Cheryl B Iglesia; Andrew I Sokol; Eric R Sokol; Bela I Kudish; Robert E Gutman; Joanna L Peterson; Susan Shott
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.661

7.  Transvaginal polypropylene mesh versus sacrospinous ligament fixation for the treatment of uterine prolapse: 1-year follow-up of a randomized controlled trial.

Authors:  Eliana Duarte Lopes; Nucélio Luiz de Barros Moreira Lemos; Silvia da Silva Carramão; Jacqueline Leme Lunardelli; José Maria Cordeiro Ruano; Tsutomu Aoki; Antonio Pedro Flores Auge
Journal:  Int Urogynecol J       Date:  2010-04       Impact factor: 2.894

8.  Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence.

Authors:  Linda Brubaker; Ingrid Nygaard; Holly E Richter; Anthony Visco; Anne M Weber; Geoffrey W Cundiff; Paul Fine; Chiara Ghetti; Morton B Brown
Journal:  Obstet Gynecol       Date:  2008-07       Impact factor: 7.661

9.  Low-weight polypropylene mesh for anterior vaginal wall prolapse: a randomized controlled trial.

Authors:  Reijo Hiltunen; Kari Nieminen; Teuvo Takala; Eila Heiskanen; Mauri Merikari; Kirsti Niemi; Pentti K Heinonen
Journal:  Obstet Gynecol       Date:  2007-08       Impact factor: 7.661

10.  Risk factors for mesh/suture erosion following sacral colpopexy.

Authors:  Geoffrey W Cundiff; Edward Varner; Anthony G Visco; Halina M Zyczynski; Charles W Nager; Peggy A Norton; Joseph Schaffer; Morton B Brown; Linda Brubaker
Journal:  Am J Obstet Gynecol       Date:  2008-10-31       Impact factor: 8.661

View more
  23 in total

Review 1.  Management options for women with uterine prolapse interested in uterine preservation.

Authors:  Nathan Kow; Howard B Goldman; Beri Ridgeway
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  Efficacy and safety of skeletonized mesh implants for advanced pelvic organ prolapse: 12-month follow-up.

Authors:  Adi Y Weintraub; Menahem Neuman; Yonatan Reuven; Joerg Neymeyer; Naama Marcus-Braun
Journal:  World J Urol       Date:  2016-02-23       Impact factor: 4.226

3.  The Design of a Randomized Trial of Vaginal Surgery for Uterovaginal Prolapse: Vaginal Hysterectomy With Native Tissue Vault Suspension Versus Mesh Hysteropexy Suspension (The Study of Uterine Prolapse Procedures Randomized Trial).

Authors:  Charles W Nager; Halina Zyczynski; Rebecca G Rogers; Matthew D Barber; Holly E Richter; Anthony G Visco; Charles R Rardin; Heidi Harvie; Dennis Wallace; Susan F Meikle
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Jul-Aug       Impact factor: 2.091

4.  Comparison of location of mesh placed transvaginally vs mesh placed abdominally at the time of sacrocolpopexy.

Authors:  Karen Noblett; Taylor Brueseke; Fritz Lin; Peter Rosenblatt
Journal:  Int Urogynecol J       Date:  2014-07-30       Impact factor: 2.894

5.  The hybrid technique of pelvic organ prolapse treatment: apical sling and subfascial colporrhaphy.

Authors:  Dmitry Shkarupa; Nikita Kubin; Alexey Pisarev; Anastasiya Zaytseva; Ekaterina Shapovalova
Journal:  Int Urogynecol J       Date:  2017-02-17       Impact factor: 2.894

6.  The resurrection of sacrospinous fixation: unilateral apical sling hysteropexy.

Authors:  Dmitry Shkarupa; Nikita Kubin; Ekaterina Shapovalova; Anastasya Zaytseva
Journal:  Int Urogynecol J       Date:  2019-06-10       Impact factor: 2.894

7.  A generic health-related quality of life instrument for assessing pelvic organ prolapse surgery: correlation with condition-specific outcome measures.

Authors:  Daniel Altman; Kirk Geale; Christian Falconer; Edward Morcos
Journal:  Int Urogynecol J       Date:  2018-03-06       Impact factor: 2.894

8.  Pelvic organ prolapse repair using the Uphold™ Vaginal Support System: a 1-year multicenter study.

Authors:  Daniel Altman; Tomi S Mikkola; Karl Möller Bek; Päivi Rahkola-Soisalo; Jonas Gunnarsson; Marie Ellström Engh; Christian Falconer
Journal:  Int Urogynecol J       Date:  2016-02-13       Impact factor: 2.894

9.  Hysterectomy with uterosacral suspension or Uphold™ hysteropexy in women with apical prolapse: a parallel cohort study.

Authors:  Mugdha Kulkarni; Natharnia Young; Joseph Lee; Anna Rosamilia
Journal:  Int Urogynecol J       Date:  2020-05-28       Impact factor: 2.894

10.  Outcomes of trocar-guided Gynemesh PS™ versus single-incision trocarless Polyform™ transvaginal mesh procedures.

Authors:  Maryse Larouche; Lisa Merovitz; José A Correa; Jens-Erik Walter
Journal:  Int Urogynecol J       Date:  2014-07-24       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.